Quantcast

Pfizer accused of not labeling warnings on Viagra labels

NORTHERN CALIFORNIA RECORD

Sunday, November 24, 2024

Pfizer accused of not labeling warnings on Viagra labels

Medical malpractice 07

SAN FRANCISCO – A Louisiana consumer is suing a pharmaceutical company over allegations that it did not label its products properly about the potential harm of Viagra.

Barry Milligan filed a complaint on April 20 in the U.S. District Court for the Northern District of California against Pfizer Inc. citing alleged breach of implied warranty, breach of express warranty, fraud, negligence and other counts.

According to the complaint, the plaintiff alleges that in June 2005 he was diagnosed with malignant melanoma when a biopsy was conducted on his left cheek. The plaintiff alleges this was caused by his prolonged usage of Viagra. The plaintiff holds Pfizer Inc. responsible because the defendant allegedly knew about the harmful effects of Viagra when it tested sildenafil, the drug's active ingredient, on rats. Despite knowing the harmful effects of the drug, the defendant allegedly chose to distribute it without providing any warnings or precautions on the drug's label.

The plaintiff requests a trial by jury and seeks all damages in an amount to be determined in trial, all legal fees and any other relief as this court deems just. He is represented by Trevor B. Rockstad and Martin D. Crump of Davis & Crump, PC in Gulfport, Mississippi.

U.S. District Court for the Northern District of California Case number 3:16-cv-02067-RS

More News